AS703569 and Gemcitabine Combination in Advanced Malignancies

NCT01097512 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: AS703569/gemcitabine
DRUG: AS703569/gemcitabine

Sponsor

Merck KGaA, Darmstadt, Germany